Massive series A rounds in December 2021 highlight new R&D trends
Shi Yingzi · 01/17/2022
Several big series A financing in December warrant attention, as they speak of a wider trend for drug innovation in China. Big pharmaceutical companies are sharing risks, and scientists are creating a mRNA platform.
READ MORE
mRNA and CNS mark November biotech fundraising in China
Shi Yingzi · 12/08/2021
Chinese drugmakers raised $1.26 billion in 28 financing rounds in November, representing the third highest amount of funds raised this year. This was mainly attributed to mRNA vaccine maker Abogen Biosciences’ $300 million series C+ round and CNS specialist Ignis Therapeutics’ $180 million series A round.
READ MORE
COVID-19 vaccine makers lose luster in October
Shi Yingzi · 11/12/2021
As vaccination rates continue to rise and therapeutic drugs for COVID-19 are coming to the market, vaccine makers are taking a hit, as reflected by their lackluster financing performance in October.
READ MORE
September fundraising puts cell therapy and immuno-oncology in the spotlight
PharmaDJ · 10/15/2021
Chinese drugmakers closed 33 financing rounds in September, raising over $1.05 billion. Oncolytic virus therapies developer Virogin Biotech and two CAR-T therapy developers were the biggest fundraisers.
READ MORE
Led by Abogen, infectious disease drugmakers post record August fundraising
Minhua Chu · 09/17/2021
Chinese biotech companies raised a total of $2.64 billion from 28 disclosed deals in August.
READ MORE
mRNA and iPSC attract investments in July
PharmaDJ · 09/10/2021
Chinese drug developers continued to close more financing deals for the fourth consecutive month.
READ MORE
COVID-19 Vaccine Developers Attract Huge Investments in June
Minhua Chu · 07/23/2021
China Biotech Fundraising Tracker: Jun 2021
READ MORE
ADCs and Immuno-Oncology Therapies Attract Massive Investments
Minhua Chu · 07/19/2021
China Biotech Fundraising Tracker: May 2021
READ MORE
China Biotech Fundraising Tracker: Apr 2021
Minhua Chu · 07/19/2021
Investors Pursuing More Opportunities With mRNA Technology.
READ MORE
READ MORE
Copyright © 2016-2022 PharmaDJ .All Rights Reserved.   Suggestions and feedback: Support@PharmaDJ.com   Record/License No.:沪ICP备17054709号-1  
About PharmaDJ | Subscription | Contact Us | Copyright Statement